CUSABIO | 助力並推進胰臟癌 (Pancreatic Cancer) 研究!

CUSABIO | 助力並推進胰臟癌 (Pancreatic Cancer) 研究!

2024.11.25

If you are unable to see the message below, click here to view.

World Pancreatic Cancer Day is on the third Thursday in November, raising awareness about pancreatic cancer, a malignant tumor in the pancreas, which is behind the stomach and helps with digestion and blood sugar control.

The cause of pancreatic cancer isn’t clear, but risk factors include smoking, obesity, diabetes, chronic pancreatitis, and family history. It has a poor prognosis, with a 5-year survival rate under 10%. Symptoms are often unnoticed until the cancer is advanced, earning it the “king of cancers” nickname.

Treatments include surgery, chemo, radiation, immunotherapy, and targeted therapy. Immunotherapy is a new focus, with drugs targeting IGF-1R, EGFR, HER2, VEGF, CTLA-4, and PD-1 in clinical trials.

CUSABIO offers a list of popular targets and products for pancreatic cancer research to assist in mechanism studies and drug development.

Hot Targets in Diabetes Research

<![if !supportLists]>·     <![endif]>ACSL4

<![if !supportLists]>·     <![endif]>AKT1

<![if !supportLists]>·     <![endif]>ANXA1

<![if !supportLists]>·     <![endif]>AXL

<![if !supportLists]>·     <![endif]>BAG3

<![if !supportLists]>·     <![endif]>CCN2

<![if !supportLists]>·     <![endif]>CCR8

<![if !supportLists]>·     <![endif]>CD274

<![if !supportLists]>·     <![endif]>CD276

<![if !supportLists]>·     <![endif]>CD3D

<![if !supportLists]>·     <![endif]>CD40

<![if !supportLists]>·     <![endif]>CD47

<![if !supportLists]>·     <![endif]>CD8A

<![if !supportLists]>·     <![endif]>CDCP1

<![if !supportLists]>·     <![endif]>CDH17

<![if !supportLists]>·     <![endif]>CEACAM1

<![if !supportLists]>·     <![endif]>CEACAM5

<![if !supportLists]>·     <![endif]>CEACAM6

<![if !supportLists]>·     <![endif]>CLDN18

<![if !supportLists]>·     <![endif]>CNTN4

<![if !supportLists]>·     <![endif]>CSF1R

<![if !supportLists]>·     <![endif]>CTLA4

<![if !supportLists]>·     <![endif]>DCLK1

<![if !supportLists]>·     <![endif]>DKK3

<![if !supportLists]>·     <![endif]>EGFR

<![if !supportLists]>·     <![endif]>ENO1

<![if !supportLists]>·     <![endif]>EPHA2

<![if !supportLists]>·     <![endif]>ERBB2

<![if !supportLists]>·     <![endif]>ERBB3

<![if !supportLists]>·     <![endif]>F3

<![if !supportLists]>·     <![endif]>FOLR1

<![if !supportLists]>·     <![endif]>FTH1

<![if !supportLists]>·     <![endif]>GAPDH

<![if !supportLists]>·     <![endif]>GCC1

<![if !supportLists]>·     <![endif]>GPC1

<![if !supportLists]>·     <![endif]>GPX4

<![if !supportLists]>·     <![endif]>HAVCR2

<![if !supportLists]>·     <![endif]>HGF

<![if !supportLists]>·     <![endif]>HMOX1

<![if !supportLists]>·     <![endif]>ICOS

<![if !supportLists]>·     <![endif]>IER3

<![if !supportLists]>·     <![endif]>IGF1R

<![if !supportLists]>·     <![endif]>IL1A

<![if !supportLists]>·     <![endif]>KEAP1

<![if !supportLists]>·     <![endif]>LOXL2

<![if !supportLists]>·     <![endif]>MELTF

<![if !supportLists]>·     <![endif]>MMP9

<![if !supportLists]>·     <![endif]>MSLN

<![if !supportLists]>·     <![endif]>MSTN

<![if !supportLists]>·     <![endif]>MTOR

<![if !supportLists]>·     <![endif]>MUC1

<![if !supportLists]>·     <![endif]>MUC16

<![if !supportLists]>·     <![endif]>NCOA4

<![if !supportLists]>·     <![endif]>NECTIN4

<![if !supportLists]>·     <![endif]>NFE2L2

<![if !supportLists]>·     <![endif]>NFKB1

<![if !supportLists]>·     <![endif]>NT5E

<![if !supportLists]>·     <![endif]>PDCD1

<![if !supportLists]>·     <![endif]>SLC3A2

<![if !supportLists]>·     <![endif]>SLC44A4

<![if !supportLists]>·     <![endif]>SLC7A11

<![if !supportLists]>·     <![endif]>TAA1

<![if !supportLists]>·     <![endif]>TACSTD2

<![if !supportLists]>·     <![endif]>TF

<![if !supportLists]>·     <![endif]>TFRC

<![if !supportLists]>·     <![endif]>TIGIT

<![if !supportLists]>·     <![endif]>TNF

<![if !supportLists]>·     <![endif]>TNFRSF10B

<![if !supportLists]>·     <![endif]>TNFRSF9

<![if !supportLists]>·     <![endif]>TP53

<![if !supportLists]>·     <![endif]>VEGFA

<![if !supportLists]>·     <![endif]>VSIR

<![if !supportLists]>·     <![endif]>ZG16B

Pancreatic Cancer Drug Target Related Products

● Target Proteins

CD40

CSB-MP004936HU1

Measured by its binding ability in a functional ELISA. Immobilized Human GIPR at 2μg/mL can bind Anti-GIPR recombinant antibody (CSB-RA009438MA1HU)the EC50 16.18-18.70 ng/mL.

CLDN18.2

CSB-MP005498HU(A5)

Measured by its binding ability in a functional ELISA. Immobilized human CLDN18.2 (CSB-MP005498HU(A5)) at 5 μg/ml can bind anti-CLDN18.2 recombinant Monoclonal Antibody (CSB-RA005498A1HU), the the EC50 is 5.225-9.256 ng/ml.

CTLA4

CSB-MP006163HU1

Measured by its binding ability in a functional ELISA. Immobilized CD152 at 2 μg/ml can bind Anti-CD152 rabbit monoclonal antibody (CSB-RA213310A0HU), the EC50 of human CD152 protein is 27.14-34.82 ng/ml

MUC16

CSB-MP704410HU3c7

Measured by its binding ability in a functional ELISA. Immobilized MUC16 at 10 μg/ml can bind MSLN (CSB-MP015044HUc9), the EC50 is 460.7-662.2 ng/ml.

 

PDCD1

CSB-MP619964HU1

Measured by its binding ability in a functional ELISA. Immobilized PD-1 at 2 μg/ml can bind Anti-PD-1 recombinant antibody, the EC50 of human PD-1 protein is 6.087-7.854 ng/ml.

TACSTD2

CSB-MP023072HU2

Measured by its binding ability in a functional ELISA. Immobilized Human TROP2 at 2 μgg/mL can bind Anti-TROP2 recombinant antibody (CSB-RA023072MA1HU), the EC50 is 0.9108-1.640 ng/mL.

TNFRSF9

CSB-MP023984HU1

Measured by its binding ability in a functional ELISA. Immobilized TNFRSF9 at 2 μg/ml can bind TNFSF9 (CSB-MP023997HU1), the EC50 is 1.011-2.429 ng/mL.

ZG16B

CSB-MP836195HU

Measured by its binding ability in a functional ELISA. Immobilized Human ZG16B at 2 μg/ml can bind Anti-ZG16B recombinant antibody (CSB-RA836195MA1HU), the EC50 is 24.13-46.04 ng/mL.

● Antibodies

CTLA4 Recombinant Monoclonal Antibody

CSB-RA006163MA1HU

Tested Applications:
ELISA, WB, IF, FC

EGFR Recombinant Monoclonal Antibody

CSB-RA159341A0HU

Tested Applications:
ELISA, WB, IHC, IF, FC

GAPDH Recombinant Monoclonal Antibody

CSB-RA009232MA1HU

Tested Applications:
ELISA, WB, IHC, IF, FC

TP53 Recombinant Monoclonal Antibody

CSB-RA024077MA1HU

Tested Applications:
ELISA, WB, IF, FC

● ELISA Kits

Mouse TNF-α ELISA KIT

CSB-E04741m

394 Citations

Human VEGF ELISA KIT

CSB-E11718h

66 Citations

Human MMP-9 ELISA Kit

CSB-E08006h

31 Citations

Human NF-κB ELISA Kit

CSB-E12107h

16 Citations

Kit

Protein

Antibody

Molecular Biology

 

CUSABIO TECHNOLOGY LLC

Postal Address:

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Website: www.cusabio.com

© 2024 CUSABIO All Products For Research Use Only

linkedInFacebookTwitterYoutube

back-Top
open-line

LINE 線上諮詢

亞旭-LINE-QRcode

掃瞄或手機直接點擊條碼

error: Content is protected !!